Stocktoria
AGILENT TECHNOLOGIES, INC. A
NYSE · XNYS · stock · Laboratory Analytical Instruments · website · IPO 1999-11-18
AGILENT TECHNOLOGIES, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.9B | $6.5B | $6.8B | $6.8B | $6.3B |
| R&D expense | $455.0M | $479.0M | $481.0M | $467.0M | $441.0M |
| SG&A expense | $1.7B | $1.6B | $1.6B | $1.6B | $1.6B |
| Operating income | $1.5B | $1.5B | $1.4B | $1.6B | $1.3B |
| Interest expense | $112.0M | $96.0M | $95.0M | $84.0M | $81.0M |
| Income tax | $132.0M | $232.0M | $99.0M | $250.0M | $150.0M |
| Net income | $1.3B | $1.3B | $1.2B | $1.3B | $1.2B |
| EPS (diluted) | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 |
| Operating cash flow | $1.6B | $1.8B | $1.8B | $1.3B | $1.5B |
| Free cash flow | $1.2B | $1.4B | $1.5B | $1.0B | $1.3B |
| Cash & equivalents | $1.8B | $1.3B | $1.6B | $1.1B | $1.5B |
| Inventory | $1.0B | $972.0M | $1.0B | $1.0B | $830.0M |
| Total assets | $12.7B | $11.8B | $10.8B | $10.5B | $10.7B |
| Total liabilities | $6.0B | $5.9B | $4.9B | $5.2B | $5.3B |
| Shareholders' equity | $6.7B | $5.9B | $5.8B | $5.3B | $5.4B |
Source: SEC EDGAR filings · CIK 0001090872 · as of 2025-10-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.